U.S. Markets closed

GTx's legacy: The once-promising pillar of Memphis' 'biotech core'

Jason Bolton
GTx's legacy: The once-promising pillar of Memphis' 'biotech core'

“We had a commercial team, a marketing team, and the sales organization. … At the last minute, the FDA decided the data was not sufficient for approval.”